Navigation Links
Dow AgroSciences Receives Approval for New Technology to Control Cotton Pests in Brazil
Date:3/19/2009

Technology incorporates naturally occurring soil micro-organism proteins to protect cotton plantations

INDIANAPOLIS and SAO PAULO, March 19 /PRNewswire/ -- Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), today announced that it has received regulatory approval from the Brazilian National Technical Commission of Biosafety (CTNBio), for its WideStrike(TM) Insect Protection technology in cotton in Brazil. WideStrike, currently marketed in the United States, provides season-long, whole-plant protection from insect feeding cotton pests.

The WideStrike technology uses two insect resistant traits that effectively control important cotton pests especially the Spodoptera frugiperda, Heliothis virescens, Pectinophora gossypiella, and the Alabama argillacea pests. Studies conducted by Dow AgroSciences and analyzed by CTNBio show that WideStrike does not create unreasonable risk to humans or the environment.

"The cultivation of cotton has gained strength in recent years in Brazil for its fiber," said Rolando Alegria, Seeds and Biotechnology director, Dow AgroSciences in Brazil. "Additionally, WideStrike contributes to a more sustainable agriculture because it controls the most harmful pests to cotton plantations. Dow AgroSciences will now be able to provide access to its company's technologies - which are among the most advanced of the world - to a larger number of growers."

Before becoming available in the Brazilian market, this technology has gone through rigorous testing in several regions of the country, and also has been tested in laboratories.

Cottonseed containing this technology has been planted since 2004 in the United States where the oil and meal produced from WideStrike cottonseed has been approved for use in human food and animal feed. These products have also been approved for use in human food and animal feed in Canada and in Japan, as well as for in human food in Mexico, South Korea, and Australia.

In December 2008, CTNBio granted its approval to Dow AgroSciences for HERCULEX(R) I Insect Protection technology that provides protection against the main corn pest in Brazil, the sugar cane borer and fall armyworm (Spodoptera frugiperda). The commercialization of the HERCULEX I hybrid corn seeds, which also produces a Bt protein to protect the plant, has already been approved by the Brazilian Ministry of Agriculture.

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $4.5 billion. Learn more at www.dowagro.com.

(TM)(R)HERCULEX and WideStrike are registered trademarks of Dow AgroSciences LLC


'/>"/>
SOURCE Dow AgroSciences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
2. Dow AgroSciences Delivering Beyond Expectations
3. Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil
4. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
5. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
6. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
7. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
8. Dow AgroSciences Success Presented to Wall Street
9. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
10. Intradigm Receives Notice of Allowance for Key RNA Interference (RNAi) Patent Covering Potent siRNA Sequence
11. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one ... of their brand, UP4™ Probiotics, into Target stores nationwide. The company, which has ... add Target to its list of well-respected retailers. This list includes such fine ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
Breaking Biology Technology:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):